Ramy Younes

Patients

The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.

News

Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ALK7.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.